Could an asthma drug curb alcohol cravings? new trial investigates.
NCT ID NCT05414240
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether ibudilast, an anti-inflammatory drug used in Japan, can help people with alcohol use disorder drink less. Fifty adults will take either ibudilast or a placebo for 6 weeks, plus counseling. The main goal is to see if it reduces the number of heavy drinking days.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Pennsylvania Center for Studies of Addiction
Philadelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a psychedelic compound help veterans and first responders with PTSD and alcohol use disorder?
- Can a brain zapping headset curb relapse in addiction?
- Zapping the brain to fight alcoholism: a new hope?
- Can a smartphone app tame Alcohol-Related liver disease?
- Calm in a room: can sensory therapy soothe the mind?
- Rewiring the brain to fight alcohol cravings?